<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="132940">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02077478</url>
  </required_header>
  <id_info>
    <org_study_id>15022014</org_study_id>
    <nct_id>NCT02077478</nct_id>
  </id_info>
  <brief_title>Total Intravenous Anesthesia: TCI Versus MCI</brief_title>
  <official_title>Total Intravenous Anesthesia: TCI Versus MCI, Unresolved Question</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli Studi di Ferrara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università degli Studi di Ferrara</source>
  <oversight_info>
    <authority>Italy: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      test the following differences between Schinder's Target Controlled Infusion (TCI ) model
      and manually controlled infusion (MCI) :

        -  remifentanil and propofol total dose given

        -  incidence of awareness or inadequate anesthesia

        -  number of rescue dose given
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>incidence of awareness or inadequate anesthesia</measure>
    <time_frame>every 3 minutes till the end of surgery</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>remifentanil and propofol total dose given</measure>
    <time_frame>every 30 minutes till the end of surgery</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Test the Differences Between Schinder's TCI Model and MCI</condition>
  <arm_group>
    <arm_group_label>MCI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>manually controlled infusion will be used</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TCI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Target Controlled Infusion will be used</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Remifentanil and propofol administration using TCI</intervention_name>
    <arm_group_label>TCI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Remifentanil and propofol administration using MCI</intervention_name>
    <arm_group_label>MCI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing breast or thyroid surgery

        Exclusion Criteria:

          -  BMI &gt; 35

          -  Surgery shorter than 30 minutes

          -  Patients with history of: alcol or drug abuse, kidney or liver failure,
             cardiovascular disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Riccardo Ragazzi</last_name>
    <phone>0532206570</phone>
    <email>rgc@unife.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>0532206570</name>
      <address>
        <city>Ferrara</city>
        <zip>44121</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Riccardo Ragazzi</last_name>
      <email>rgc@unife.it</email>
    </contact>
    <investigator>
      <last_name>Riccardo Ragazzi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Russell D. Intravenous anaesthesia: manual infusion schemes versus TCI systems. Anaesthesia. 1998 Apr;53 Suppl 1:42-5. Review.</citation>
    <PMID>9640114</PMID>
  </reference>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 26, 2014</lastchanged_date>
  <firstreceived_date>February 19, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università degli Studi di Ferrara</investigator_affiliation>
    <investigator_full_name>Riccardo Ragazzi</investigator_full_name>
    <investigator_title>Associated professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
